Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA ligase is an essential enzyme involved in joining breaks in the phosphodiester backbone of DNA by catalyzing the formation of covalent phosphodiester bonds between adjacent 5′ phosphate and 3′ hydroxyl ends in DNA. It is required for the completion of DNA replication (joining of Okazaki fragments on the lagging strand), for repairing single- and double-strand DNA breaks during DNA repair pathways (including base excision repair, nucleotide excision repair, and nonhomologous end joining), and for facilitating genetic recombination. DNA ligases are found in all forms of life and belong to the nucleotide transferase superfamily. Their mechanism involves an initial adenylation of a conserved lysine residue by ATP or NAD⁺, transfer of an AMP group to the 5′ phosphate DNA end forming a reactive intermediate, and finally phosphodiester bond formation linking DNA ends and releasing AMP. Multiple isoforms exist in higher organisms (e.g., DNA ligase I, III, IV in humans), each with distinct but sometimes overlapping functions—some specialized for specific repair processes (e.g., Ligase IV in nonhomologous end-joining). DNA ligases are critical for genome stability, and their dysfunction is linked to disease, while their unique functional domains in bacteria make them targets for antibacterial drug development. In research, DNA ligases are widely used in molecular cloning for the construction of recombinant DNA molecules.
Enzyme inhibition (small-molecule inhibitors block the ligase’s catalytic activity, preventing DNA strand joining and causing DNA break accumulation); Sensitization to DNA-damaging agents (inhibitors make cancer cells more susceptible to chemotherapy/radiation); Antibiotic action (selective targeting of bacterial NAD⁺-dependent DNA ligase disrupts bacterial DNA repair/replication, causing cell death)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA ligase.